Table 3.
Hypertension Medication Class | N | Column Percent |
---|---|---|
No HTN prescriptions filled | 600 | 20% |
Single Medication Class | 865 | 28% |
Diuretics | 244 | |
Angiotensin-converting enzyme (ACE) inhibitors, ACE Inhibitor/diuretic combinations (ACE) | 232 | |
Calcium channel blockers (CCB) | 235 | |
Angiotensin receptor blockers, angiotensin receptor blockers/diuretic angiotensin receptor modulators (AR) | 88 | |
Beta blockers, beta blockers/diuretic combinations (BB) | 51 | |
Sympatholytics | 13 | |
Bidil, hydralazine | 2 | |
Two Medication Classes * | 811 | 27% |
Diuretics plus CCB | 184 | |
Diuretics plus ACE | 150 | |
Diuretics plus AR | 51 | |
ACE plus CCB | 128 | |
AR plus CCB | 84 | |
BB plus CCB | 58 | |
Other two class combinations | 156 | |
Three Medication Classes * | 499 | 16% |
Diuretics + BB + CCB | 50 | |
Diuretics + AR + CCB | 64 | |
Diuretics + ACE + CCB | 132 | |
Other 3 class combinations | 253 | |
Four Medication Classes * | 194 | 6% |
Five or more Medication Classes * | 75 | 2% |
Only listed two or more medication classes if N ≥ 50.